Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Mangoceuticals, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 10 | 11 | +1 |
| Shares | 292.3K | 374.6K | +82.3K (+28.2%) |
| Value | $444.2K | $820.1K | +$375.8K (+84.6%) |
New holders (4)
Institutions that held Mangoceuticals, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 28,514 | $62.4K | 0.00% |
| Northern Trust Corp | 18,957 | $41.5K | 0.00% |
| Sunbelt Securities, Inc. | 7,000 | $15.3K | 0.00% |
| Royal Bank of Canada | 451 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Mangoceuticals, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Renaissance Technologies LLC | 31,000 | $47.1K |
| Goldman Sachs Group Inc | 10,570 | $16.1K |
| Tower Research Capital LLC (TRC) | 1,850 | $2.81K |